Time to allow visits: Vaccine success supports reopening in long-term care, advocates say
By
Alicia Lasek
Feb 26, 2021
State and federal officials are being urged to ease visitation restrictions as COVID-19 vaccinations continue and cases fall among residents.
Makers of newer vaccines tout advantages as trial results and approvals announced
By
Alicia Lasek
Feb 01, 2021
Two drugmakers say their vaccines, which include J&J’s one-dose candidate, are effective against new coronavirus variants, while AstraZeneca’s vaccine is now approved for adults across the...
Opioid pain relief not necessary after knee surgery, orthopedic surgeons say
By
Alicia Lasek
Apr 27, 2021
Patients given a non-opioid pain regimen after knee surgery had pain scores equal to their peers who received opioids, and no difference in side effects, according to a study by orthopedic surgeons.
Black patients less likely to seek hospice care than whites, researchers say
By
Alicia Lasek
Oct 29, 2020
Black patients seek substantially more intensive medical treatment in the last six months of life than whites, a study shows. The investigators recommend that more healthcare providers are trained to promote...
Diabetes risk impacted more by excess weight than genetics, experts say
By
Alicia Lasek
Sep 01, 2020
Bringing weight below an individualized “trigger” threshold could prevent or even reverse the disease, the results of a new study indicate.
U.S. Senate committee urged to follow SNFs’ lead in falls prevention
By
Alicia Lasek
Oct 16, 2019
Lawmakers should consider changes to Medicare and look to nursing facilities’ experience when addressing fall-related injuries in seniors, says LeadingAge.
New resident with pneumonia? Better check for excessive antibiotic use
By
Alicia Lasek
Jul 09, 2019
Two-thirds of hospitalized pneumonia patients are discharged with unnecessarily long prescriptions, a Michigan study has found.
Engage! When social involvement declines, cognitive abilities may follow
By
Alicia Lasek
Jun 28, 2019
Social engagement may be a mark of how resilient – or vulnerable – someone is to cognitive decline, a recent study has found.
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
Levodopa does not relieve speech symptoms in early Parkinson’s, study finds
By
Alicia Lasek
Mar 10, 2022
The gold standard drug used to treat symptoms of Parkinson’s disease does not appear to have an effect on speech early in the disease course, investigators say.